IBX (ASX) Consolidation in effect today

Originally posted by stevenjd: ↑

There are revenue sales for third parties, just think about that alone for a 10m med tech.

Then consider the sort of news flow that is in the making. , - if i interpret what was highlighted, that they are out to partnering the phase 2 trial. Makes sense to share the capital outlay, and benefit to whoever it is. ?? What comes of the market whose wind then sees the combined momentum sails ?

As well as other third party collaborations. All stacked on top of one metric. 10m mc. today.
In med tech space, thats pretty hard to find, especially when you have a Major Imagining Seimens already collaborating, and you get it this cheap when others are capitulating. That is the market in action. There is the high side, the fever with the music and believers in tune, and then there is the low side, like a bunch of sea sick vomiting sods.

But the cold hard facts, emotion aside from either high or low, is that this is a promising med tech, with a proven IP so far. It already worked in vitro MRX, and the phase 1 study was about safety and bio kinetics in people. The NPs with targeting ligands are safe,, look to be capable of finding their target (where the drainage path is clear to do so, noting the excluded cases where said were drainage blocked by cancer). And have third parties already on board piggy backing our tech for their own application.

The scale ahead of us, other cancer types, where we look at other cancers say prostate ? etc. its going to be up to the experts to determine to where you inject the NPs. etc.

And what the market makes of additional collaborations..All for 10m mc. That window of discount, you get because of bed wetters. Accumulate over a range of discounts. For mine, happy with initial, then i wait for a leg down, for next.

Not investment advice.

Expand

Thank you Stevo.

But your posts tend to completely ignore the company's financials.

Where is the money for Phase 2 going to come from?

All funding avenues have dried up. Because:

Shareholders (on the information currently before them) refuse to fund.

Imagion cannot obtain further loan funds as they have an extremely modest revenue base. To date the company has been living off CRs and some form of ATO R&D tax rebate where apparently the R&D has been completed offshore (are these presently under ATO review? - not sure), some modest sales revenue, and a Mercer loan facility.

And any US hospital facility would want to see Imagion's financials right upfront before entering into any Phase 2 agreement. That would be interesting.

And Imagion, at this point in time, would have their Auditors right up their clacker re going concern issues.

So a partner (or a joint venturer) appears to be Imagion's last roll of the dice.

A lot of touting about Siemens - but they remain largely silent. And I haven't seen any other interested parties. But interested partners do seem to loiter, "vulture like", and have a tendency to come out of the woodwork at Chapter 11 time.

Stevo - please consider the financial side instead of waxing non-stop lyrical about the tech.

The tech may be brilliant and there is a real possibility that it will be successfuly brought to market at some time. But by Imagion?

The above are definitely only the incoherent observations of Stretguy. Definitely do your own research.

Regards
Stretguy.